These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16686837

  • 1. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL, Foster GA, Dodd RY.
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM, Remesar M, del Pozo A, Sen L.
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP, Laycock M, Kleinman SH, Wages JW, Calabro M, Kaplan JE, Khabbaz RF, Hollingsworth CG.
    Blood; 1994 Feb 15; 83(4):1143-8. PubMed ID: 8111054
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing.
    Nowicki MJ, Matsuoka L, Brucal D, Chinchilla C, Mone T, Selby R, Mendez R.
    Transplantation; 2006 Nov 15; 82(9):1210-3. PubMed ID: 17102773
    [Abstract] [Full Text] [Related]

  • 8. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY, Lim AH, Park JY, Han SH, Cho NS.
    J Med Virol; 2008 Oct 15; 80(10):1864-7. PubMed ID: 18712809
    [Abstract] [Full Text] [Related]

  • 9. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araujo A.
    J Clin Virol; 2008 Jun 15; 42(2):149-55. PubMed ID: 18346935
    [Abstract] [Full Text] [Related]

  • 10. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD.
    Arch Intern Med; 1991 Oct 15; 151(10):2043-8. PubMed ID: 1929693
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
    Niazi SK, Bhatti FA, Salamat N.
    J Coll Physicians Surg Pak; 2015 Dec 15; 25(12):874-7. PubMed ID: 26691361
    [Abstract] [Full Text] [Related]

  • 13. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
    Sagara Y, Nakamura H, Yamamoto M, Ezaki T, Koga T, Shimamura M, Satake M, Irita K.
    Transfusion; 2021 Feb 15; 61(2):484-493. PubMed ID: 33368334
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
    Malm K, Kjerstadius T, Andersson S.
    J Med Virol; 2010 Sep 15; 82(9):1606-11. PubMed ID: 20648617
    [Abstract] [Full Text] [Related]

  • 15. Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients.
    Fischer HE, Lichtiger B, Glassman AB.
    Ann Clin Lab Sci; 1995 Sep 15; 25(5):373-80. PubMed ID: 7486811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discordant human T-lymphotropic virus screening with Western blot confirmation: evaluation of the dual-test algorithm for US blood donations.
    Stramer SL, Townsend RL, Foster GA, Johnson R, Weixlmann B, Dodd RY.
    Transfusion; 2018 Mar 15; 58(3):638-640. PubMed ID: 29322517
    [Abstract] [Full Text] [Related]

  • 18. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R, Turhan A, Bozkurt H, Samlıoğlu P, Değirmenci A, Aydınok Y, Erensoy S.
    Mikrobiyol Bul; 2010 Oct 15; 44(4):579-84. PubMed ID: 21063970
    [Abstract] [Full Text] [Related]

  • 19. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA, Eirin ME, Pando MA, Biglione MM.
    J Med Virol; 2007 Jan 15; 79(1):69-73. PubMed ID: 17133550
    [Abstract] [Full Text] [Related]

  • 20. Human T-lymphotropic virus type I/II. Status of enzyme immunoassay and western blot testing in the United States in 1989 and 1990.
    Blumer SO, Hearn TL, Schalla WO, Cross GD, Valdiserri RO.
    Arch Pathol Lab Med; 1992 May 15; 116(5):471-6. PubMed ID: 1316110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.